
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Xiaohu Zheng, Yeben Qian, Binqing Fu, et al.
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1656-1667
Closed Access | Times Cited: 214
Xiaohu Zheng, Yeben Qian, Binqing Fu, et al.
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1656-1667
Closed Access | Times Cited: 214
Showing 1-25 of 214 citing articles:
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad, Beth A. Helmink, Padmanee Sharma, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5309-5337
Open Access | Times Cited: 1083
Golnaz Morad, Beth A. Helmink, Padmanee Sharma, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5309-5337
Open Access | Times Cited: 1083
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan, Hualing Zhang, Junnian Zheng, et al.
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 605-618
Open Access | Times Cited: 732
Qianqian Duan, Hualing Zhang, Junnian Zheng, et al.
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 605-618
Open Access | Times Cited: 732
Natural killer cells in cancer biology and therapy
Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 626
Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 626
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Wen Chen, Huakan Zhao, Yongsheng Li
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 399
Wen Chen, Huakan Zhao, Yongsheng Li
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 399
Tumor-Infiltrating Natural Killer Cells
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 354
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 354
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells
Hao Song, Jiaxi Song, Ming Cheng, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 144
Hao Song, Jiaxi Song, Ming Cheng, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 144
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 140
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 140
CAR‐NK cell in cancer immunotherapy; A promising frontier
Faroogh Marofi, Omar F. Abdul‐Rasheed, Heshu Sulaiman Rahman, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3427-3436
Open Access | Times Cited: 122
Faroogh Marofi, Omar F. Abdul‐Rasheed, Heshu Sulaiman Rahman, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3427-3436
Open Access | Times Cited: 122
Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors
Jang Hyun Park, Hyun-Jin Kim, Chae Won Kim, et al.
Nature Immunology (2021) Vol. 22, Iss. 3, pp. 336-346
Closed Access | Times Cited: 105
Jang Hyun Park, Hyun-Jin Kim, Chae Won Kim, et al.
Nature Immunology (2021) Vol. 22, Iss. 3, pp. 336-346
Closed Access | Times Cited: 105
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 98
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 98
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
Shijun Ma, Yue Zhao, Wee Chyan Lee, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
Shijun Ma, Yue Zhao, Wee Chyan Lee, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
Tumor hypoxia: From basic knowledge to therapeutic implications
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 89
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 89
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 81
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 81
Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
Jang Hyun Park, Heung Kyu Lee
Cancers (2022) Vol. 14, Iss. 5, pp. 1176-1176
Open Access | Times Cited: 70
Jang Hyun Park, Heung Kyu Lee
Cancers (2022) Vol. 14, Iss. 5, pp. 1176-1176
Open Access | Times Cited: 70
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Role of mitochondrial alterations in human cancer progression and cancer immunity
Sheng‐Fan Wang, Ling‐Ming Tseng, Hsin‐Chen Lee
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 62
Sheng‐Fan Wang, Ling‐Ming Tseng, Hsin‐Chen Lee
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 62
Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation
Yu Sun, Haoran Hu, Zheng Liu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e006481-e006481
Open Access | Times Cited: 53
Yu Sun, Haoran Hu, Zheng Liu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e006481-e006481
Open Access | Times Cited: 53
Tumors evade immune cytotoxicity by altering the surface topology of NK cells
Xiaohu Zheng, Zhuanghao Hou, Yeben Qian, et al.
Nature Immunology (2023) Vol. 24, Iss. 5, pp. 802-813
Closed Access | Times Cited: 49
Xiaohu Zheng, Zhuanghao Hou, Yeben Qian, et al.
Nature Immunology (2023) Vol. 24, Iss. 5, pp. 802-813
Closed Access | Times Cited: 49
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 32
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 32
Mitochondrial quality control in human health and disease
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 30
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 24
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 24
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
Shiyong Neo, Le Tong, Joni Chong, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 18
Shiyong Neo, Le Tong, Joni Chong, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 747
Closed Access | Times Cited: 18
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Luana Guerra, Lynn Bonetti, Dirk Brenner
Cell Reports (2020) Vol. 32, Iss. 1, pp. 107848-107848
Open Access | Times Cited: 133
Luana Guerra, Lynn Bonetti, Dirk Brenner
Cell Reports (2020) Vol. 32, Iss. 1, pp. 107848-107848
Open Access | Times Cited: 133